Literature DB >> 24237583

Reliability and Validity of the Persian HIT-6 Questionnaire in Migraine and Tension-type Headache.

Alireza Zandifar1,2, Mahboobeh Banihashemi1, Faraidoon Haghdoost1, Samaneh S Masjedi1, Navid Manouchehri1, Fatemeh Asgari1, Mohammad R Najafi3, Abbas Ghorbani3, Samaneh Zandifar2, Mohammad Saadatnia2,3, Michelle K White4.   

Abstract

OBJECTIVE: Headache Impact Test (HIT-6) measures the impact headaches in a 1-month period. We validated the Persian translation of HIT-6, compared the HIT-6 psychometric analysis between migraine and tension-type headache (TTH) patients, and evaluated the capability of HIT-6 to differentiate between TTH, chronic migraine, and episodic migraine.
METHODS: Qualified participants, including 274 patients diagnosed with migraine or TTH, were required to complete HIT-6, SF-36v2, and a symptoms questionnaire on their first visit. At 3 and 8 weeks from first visit, participants completed HIT-6. Internal consistency (Cronbach's α) and test-retest reproducibility (Pearson's correlation coefficient) were used to assess reliability. Convergent validity was also assessed.
RESULTS: Tension-type headache, episodic, and chronic migraines included 24.5%, 61.9%, and 13.6% of the participants, respectively. Internal consistency among all patients, TTH, and migraine in the first visit were 0.74, 0.77, and 0.73, respectively. Test-retest reliability for HIT-6 between visit 1 and 2 showed a moderate level of correlation (r = 0.50). Convergent validity and also item total correlation were acceptable. There was no significant difference in HIT-6 total score between TTH and migraine.
CONCLUSION: Persian HIT-6 is a valid and reliable questionnaire for the evaluation of headache. However, it cannot differentiate between chronic migraine, episodic migraine, and TTH in Iranian population.
© 2013 World Institute of Pain.

Entities:  

Keywords:  HIT-6; Headache Impact Test; Persian; migraine; reliability; tension-type headache; validity

Mesh:

Year:  2013        PMID: 24237583     DOI: 10.1111/papr.12120

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  10 in total

1.  Association between Ala379Val polymorphism of lipoprotein-associated phospholipase A2 and migraine without aura in Iranian population.

Authors:  Faraidoon Haghdoost; Mahsa Gharzi; Farough Faez; Elinaz Hosseinzadeh; Mohamadhasan Tajaddini; Laleh Ra Ei; Fatemeh Asgari; Mahboobeh Banihashemi; Samaneh Sadat Masjedi; Alireza Zandifar; Shaghayegh Haghjooy-Javanmard
Journal:  Iran J Neurol       Date:  2016-04-03

2.  Effects of Valeriana officinalis (Valerian) on tension-type headache: A randomized, placebo-controlled, double-blind clinical trial.

Authors:  Hossein Azizi; Asie Shojaii; Fataneh Hashem-Dabaghian; Mohammadreza Noras; Amirreza Boroumand; Bita Ebadolahzadeh Haghani; Roshanak Ghods
Journal:  Avicenna J Phytomed       Date:  2020 May-Jun

3.  Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.

Authors:  Kerstin Luedtke; Annika Basener; Stephanie Bedei; Rene Castien; Aleksander Chaibi; Deborah Falla; Cesar Fernández-de-Las-Peñas; Mirja Gustafsson; Toby Hall; Gwen Jull; Peter Kropp; Bjarne K Madsen; Benjamin Schaefer; Elizabeth Seng; Claudia Steen; Peter Tuchin; Harry von Piekartz; Bettina Wollesen
Journal:  BMJ Open       Date:  2020-02-12       Impact factor: 2.692

4.  Reliability and Validity of Turkish Version of Headache Impact Test (HIT-6) in Patients with Migraine.

Authors:  Pınar Yalinay Dikmen; Mumine Bozdağ; Mumin Güneş; Seda Koşak; Bahar Taşdelen; Derya Uluduz; Aynur Ozge
Journal:  Noro Psikiyatr Ars       Date:  2020-04-24       Impact factor: 1.339

5.  The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines.

Authors:  Mahnaz Rezaei Kelishadi; Amirmansour Alavi Naeini; Fariborz Khorvash; Gholamreza Askari; Zahra Heidari
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  Association between dietary acid load and clinical features of migraine headaches among Iranian individuals.

Authors:  Keyhan Lotfi; Gholamreza Askari; Hamed Mohammad; Abdulmannan Fadel; Fariborz Khorvash; Arman Arab
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

7.  The efficacy of transdiagnostic cognitive behavioral therapy on migraine headache: a pilot, feasibility study.

Authors:  Forouzandeh Soleimanian-Boroujeni; Negin Badihian; Shervin Badihian; Vahid Shaygannejad; Yousef Gorji
Journal:  BMC Neurol       Date:  2022-06-22       Impact factor: 2.903

8.  Increased GABA+ in People With Migraine, Headache, and Pain Conditions- A Potential Marker of Pain.

Authors:  Aimie L Peek; Andrew M Leaver; Sheryl Foster; Georg Oeltzschner; Nicolaas A Puts; Graham Galloway; Michele Sterling; Karl Ng; Kathryn Refshauge; Maria-Eliza R Aguila; Trudy Rebbeck
Journal:  J Pain       Date:  2021-06-25       Impact factor: 5.820

9.  Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients.

Authors:  Alireza Zandifar; Fatemeh Asgari; Faraidoon Haghdoost; Samaneh Sadat Masjedi; Navid Manouchehri; Mahboobeh Banihashemi; Abbas Ghorbani; Mohammad Reza Najafi; Mohammad Saadatnia; Richard B Lipton
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

10.  Longitudinal Modeling of Non-Pharmacological Factors Related to Frequency, Severity and Duration in Both Migraine and Tension-Type Headaches.

Authors:  Somaye Hosseini; Reyhaneh Rikhtehgaran; Mohammad Saadatnia; Alireza Zandifar; Marjan Mansourian
Journal:  J Res Health Sci       Date:  2020-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.